Why CNS Pharmaceuticals Shares Are Trading Higher Today

by Anusuya Lahiri, Benzinga Editor

April 17, 2023 11:53 AM | 1 min read |

CNS Pharmaceuticals, Inc CNSP shares gained after the company disclosed the stock purchase by CEO John M Climaco and director Jerzy Gumulka.
Climaco purchased 15,000 shares at an average price of $0.69 per share on April 14, and director Gumulka bought 7,173 shares at an average price of $0.74 on April 17.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for treating primary and metastatic cancers of the brain and central nervous system.
Price Action: CNSP shares traded higher by 36.20% at $3.20 on the last check Monday.

Posted In:

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.